References
- FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
- NagaiKYoshidaJNishimuraMPostoperative mortality in lung cancer patientsAnn Thorac Cardiovasc Surg200713637337718292718
- ColinetBJacotWBertrandDA new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson’s indexBr J Cancer200593101098110516234816
- CrinoLWederWvan MeerbeeckJFelipEEarly stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201021Suppl 5v103v11520555058
- JørgensenTLHallasJFriisSHerrstedtJComorbidity in elderly cancer patients in relation to overall and cancer-specific mortalityBr J Cancer201210671353136022353805
- DeleuranTSøgaardMFrøslevTCompleteness of TNM staging of small-cell and non-small-cell lung cancer in the Danish cancer registry, 2004–2009Clin Epidemio20124 Suppl 23944
- YoungRPHopkinsRJChristmasTBlackPNMetcalfPGambleGDCOPD prevalence is increased in lung cancer, independent of age, sex and smoking historyEur Respir J 20092009342380386
- DollRHillABThe mortality of doctors in relation to their smoking habits: a preliminary report. 1954BMJ2004328745515291533 discussion 153315217868
- ViegiGScognamiglioABaldacciSPistelliFCarrozziLEpidemiology of chronic obstructive pulmonary disease (COPD)Respiration200168141911223724
- Janssen-HeijnenMLSmuldersSLemmensVESmeenkFWvan GeffenHJCoeberghJWEffect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancerThorax200459760260715223870
- AsmisTRDingKSeymourLAge and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trialsJ Clin Oncol2008261545918165640
- StrandTERostadHWentzel-LarsenTvon PlessenCA population-based evaluation of the seventh edition of the TNM system for lung cancerEur Respir J201036240140720075046
- BlancoJATosteISAlvarezRFCuadradoGRGonzalvezAMMartinIJAge, comorbidity, treatment decision and prognosis in lung cancerAge Ageing200837671571819004964
- TammemagiCMNeslund-DudasCSimoffMKvalePImpact of comorbidity on lung cancer survivalInt J Cancer2003103679280212516101
- BattafaranoRJPiccirilloJFMeyersBFImpact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancerJ Thorac Cardiovasc Surg2002123228028711828287
- VultoAJLemmensVELouwmanMWThe influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002Cancer2006106122734274216703598
- GrønbergBHSundstrømSKaasaSInfluence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapyEur J Cancer201046122225223420471248
- ReadWLTierneyRMPageNCDifferential prognostic impact of comorbidityJ Clin Oncol200422153099310315284260
- Danish Health and Medicines AuthorityThe National Cancer Plan Summary and RecommendationsCopenhagenNational Board of Health2005 Available from: http://www.sst.dk/publ/Publ2005/PLAN/kraeft-plan2/KraeftplanII_UK/Kraeftplan_II_UK.pdfAccessed February 5, 2013
- Danish Health and Medicines AuthorityNational Integrated Cancer PathwaysCopenhagenNational Board of Health2009 Available from: http://www.sst.dk/English/Cancer_pathways.aspxAccessed February 5, 2013
- National auditrapport januar 2011 – december 2011 [Danish]CopenhagenDansk Lunge Cancer Register2011 Available from: http://www.lunge-cancer.dk/documents/00224.pdfAccessed December 4, 2012
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
- QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care200543111130113916224307
- BrennerHRachetBHybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident casesEur J Cancer200440162494250115519525
- RamseySDHowladerNEtzioniRDDonatoBChemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-MedicareJ Clin Oncol200422244971497815611512
- D’AddarioGFruhMReckMBaumannPKlepetkoWFelipEMetastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201021 Suppl 5v116v11920555059
- SøgaardMKornumJBSchønheyderHCThomsenRWPositive predictive value of the ICD-10 hospital diagnosis of pleural empyema in the Danish National Registry of PatientsClin Epidemiol20113858921386977
- ThomsenRWLangePHellquistBValidity and underrecording of diagnosis of COPD in the Danish National Patient RegistryRespir Med201110571063106821320769
- Kort- og langtidsoverlevelse efter indlæggelse for udvalgte kræftsyg-domme i Nordjyllands, Viborg og Århus amter 1985–2003 [Danish]Department of Clinical Epidemiology, Aarhus University Hospital Available from: http://kea.au.dk/files/25.pdfAccessed 2005
- GjerstorffMLThe Danish Cancer RegistryScand J Public Health201139Suppl 7424521775350
- ThygesenSKChristiansenCFChristensenSLashTLSørensenHTThe predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Med Res Methodol2011118321619668